Thymidylate synthase, dihydrofolate reductase, and other folate-dependent enzymes

The phrase "thymidylate synthase, dihydrofolate reductase, and other folate-dependent enzymes" is not a single, unified molecular target. It encompasses a heterogeneous class of distinct enzymes involved in folate metabolism and DNA synthesis. While individual components like Thymidylate synthase (TS) and Dihydrofolate reductase (DHFR) are well-defined therapeutic targets, this composite term is too broad and non-specific for structured biomedical data applications. Each distinct enzyme has its own canonical name, function, and associated drugs, making the generic grouping problematic for precise targeting and database entry.

This query refers to multiple distinct enzyme targets within the folate metabolic pathway. Drugs targeting these enzymes act via various mechanisms, including inhibition of dTMP synthesis (Thymidylate synthase), competitive inhibition of dihydrofolate reduction (Dihydrofolate reductase), and other mechanisms depending on the specific folate-dependent enzyme targeted. This composite term itself does not represent a single mechanism of action.